Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Merck KGaA | 3 | 1 | 0 | 0 | €155.20 | €146.00 | -5.928% |
| Evotec SE | 6 | 2 | 2 | 1 | €8.83 | €21.50 | 143.626% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.55 | €65.00 | -3.775% |
| QIAGEN NV | 10 | 0 | 2 | 0 | €40.47 | €47.84 | 18.212% |
| AstraZeneca plc | 2 | 0 | 0 | 0 | €147.95 | €165.00 | 11.524% |
| Sanofi S.A. | 7 | 0 | 4 | 0 | €90.32 | €99.50 | 10.164% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €172.50 | -6.757% |
| Pfizer Inc. | 31 | 4 | 4 | 0 | €25.68 | €41.10 | 60.090% |
| Johnson & Johnson | 38 | 1 | 6 | 0 | €137.50 | €187.15 | 36.111% |
| Merck & Co. Inc. | 33 | 1 | 5 | 0 | €123.20 | €125.66 | 1.995% |
| Biogen Inc. | 52 | 1 | 4 | 0 | €210.10 | €293.22 | 39.564% |
| Amgen Inc. | 26 | 0 | 1 | 0 | €292.90 | €300.48 | 2.588% |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 11 | 0 | €1,000.5 | €1,048.1 | 4.754% |
| Vertex Pharmaceuticals Inc. | 51 | 2 | 6 | 0 | €443.70 | €429.98 | -3.091% |
| Gilead Sciences Inc | 15 | 1 | 4 | 0 | €64.89 | €79.54 | 22.581% |
| Abbott Laboratories | 18 | 0 | 1 | 0 | €98.19 | €116.48 | 18.627% |
| Eli Lilly Corp. | 67 | 0 | 20 | 0 | €843.70 | €880.00 | 4.302% |
| Viatris Inc. | 2 | 0 | 1 | 0 | €9.77 | €12.00 | 22.825% |